Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Chris Wendt (Minneapolis, United States of America), Brian Sandri, Andrew Limper, Pratik Jagtap, Svetlana Avdulov, Mark Peterson, Ping Yang, Ola Larsson, Carl Murie, Peter Bitterman, Tim Griffin, LeeAnn Higgins, Todd Markowski, Chris Wendt. Large-scale quantitative proteomic analysis identifies pathways in COPD-associated lung cancer. Eur Respir J 2015; 46: Suppl. 59, 4270

Member's Comments

No comment yet.

Related content which might interest you: Exploring the 24h-effect of targeted therapies in non-small cell lung cancer from exon array blood profiling using dually constrained correspondence analysis Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 DNA methylation profiling of non-small cell lung cancer reveals an immune signature in COPD patients Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome) Year: 2013 Telomere-associated gene network in lung adenocarcinoma Source: International Congress 2015 – Respiratory translational research: novel mechanisms, diagnostic markers and Space Odyssey Year: 2015 Exploiting metabolomic approaches to aid in the diagnosis of lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016 Metabolomic profiling of clinical sputum samples reveals novel biomarkers for the early identification of lung cancer patients Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Metabolic modification as a potential therapeutics approach in lung cancer Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013 High-throughput detection of alternative splicing in patients with non-small cell lung cancer treated by bevacizumab/erlotinib Source: International Congress 2014 – Novel approaches in transcriptomics and epigenomics in inflammatory lung diseases and lung cancer Year: 2014 The utility of bronchoscopically acquired tissue for successful lung cancer molecular profiling (LC-MP) Source: Annual Congress 2013 –Comfort, safety and effectiveness of bronchoscopy Year: 2013 COPD and lung cancer: Prevalence, infradiagnosis, phenotypes and multidimensional characterization Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer Year: 2016 Determining genomic rearrangements in clinical lung specimens for assessment of metastatic disease, actionable targets and disease monitoring Source: International Congress 2016 – New genomic targets in pulmonary disease Year: 2016 Optimization of cfDNA routine use for NSCLC genomic alteration analysis Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease Year: 2016 Significance of EGFR expression patterns in patients with non-small cell lung cancer – Evaluation on protein- and/or gene level? Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Potential genetic markers for the early diagnosis of peripheral and metastatic lung cancer Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Expression analysis of miR-21 in Bulgarian patients with non-small cell lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Automated target-FISH lung cancer detection (LCD) test of induced sputum Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 A functional polymorphism in XRCC1 gene is associated with lung cancer risk in a Korean population Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 The methylation profiling of multiple tumor suppressor genes in plasma cell-free DNA from patients with NSCLC versus non-malignant tumors - pilot study Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases Year: 2014 Comparative analysis of lung cancer driver mutations from FFPE samples and liquid biopsies by IonTorrent next generation sequencing Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016 Network-based approach identifies SP1 as a common node in emphysema and lung cancer Source: International Congress 2014 – Mechanisms of COPD and inhalation injury Year: 2014